View as Webpage

Products

Support

Insights

Resources

About Us

Unlocking Vaccines with Protein Structure – Nipah & Hendra Virus

Nipah virus (NiV) and Hendra virus (HeV) are highly pathogenic bat-borne paramyxoviruses included in the WHO Blueprint priority diseases list. NiV has two membrane-anchored glycoproteins, the attachment protein (G) and fusion (F) protein, that mediate receptor binding and entry into host cells. G binding to the cellular receptor, ephrin-B2 or -B3, triggers a conformational change in F that facilitates fusion of the viral and cellular membranes.

Using high-quality and correct virus antigens for immunization can help you obtain optimal results when it comes to vaccine development, especially when it comes to the correct native structure or protein conformation. Put your trust in ACROBiosystems’ verified viral antigens to accelerate your vaccine development.

Explore our NiV and HeV Antigens here or glance at our catalog >>

Nipah Virus (NiV) Antigens

Hendra Virus (HeV) Antigens

Pre-F (Cat. No. FUN-N52H3)

Pre-F (Cat. No. FUN-H52H4)

Post-F (Cat. No. PON-V52H3)

---

G (Cat. No. GLN-N52H3)

G (Cat. No. GLN-H52H3)

Verifying Pre / Post – Fusion NiV Glycoprotein by ELISA

Immobilized Nipah virus Post-Fusion glycoprotein, His Tag (Cat. No. PON-V52H3) at 2 μg/mL (100 μL/well) can not bind Anti-HeV/NiV F/Fusion glycoprotein F0 Antibody (5B3) with a linear range of 0.002-0.156 μg/mL (QC tested).

Click to Request for the Protocol

Pseudovirus Service for Vaccine Development 

Pseudoviruses are becoming a critical component of the vaccine development process, helping simulate the process of infecting cells and evaluate antibody neutralization activity.

Let us know how we can help accelerate your vaccine development. Click below to learn more and inquire about our Pseudovirus services! 

Learn more

To receive the latest industry news and updates from ACROBiosystems,

visit our website & follow us on our social media!

Visit our Website
LinkedIn  Twitter  YouTube  Facebook